Specifically in patients with advanced stages of chronic kidney disease, both the diagnostic and prognostic accuracy of NT-proBNP were limited within the present all-comer study, including patients hospitalized with HFmrEF. The gene discussed is NPPB; the disease is chronic kidney disease.